A high-throughput liquid bead array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity

A detailed understanding of the adaptive host response to SARS-CoV-2 infection in humans is urgently needed. We developed a sensitive, high-throughput, and efficient assay using liquid bead array technology. We observed advantages over traditional ELISA for the detection and quantification of bindin...

Full description

Saved in:
Bibliographic Details
Published in:iScience Vol. 24; no. 2; p. 102052
Main Authors: Bennett, Monique, Yoder, Sandra, Brady, Eric, Pulley, Jill M., Rhoads, Jillian P., Stewart, Thomas G., Bernard, Gordon R., Creech, C. Buddy, Wheeler, Allison P., Thomsen, Isaac
Format: Journal Article
Language:English
Published: United States Elsevier Inc 19-02-2021
Elsevier
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A detailed understanding of the adaptive host response to SARS-CoV-2 infection in humans is urgently needed. We developed a sensitive, high-throughput, and efficient assay using liquid bead array technology. We observed advantages over traditional ELISA for the detection and quantification of binding IgG against the receptor binding domain (RBD) of SARS-CoV-2. To determine whether COVID-19 symptom severity correlates with SARS-CoV-2 IgG, we measured anti-RBD IgG levels from 67 subjects recovered from PCR-confirmed COVID-19. We found that COVID-19 symptom severity strongly correlated with RBD IgG level (p < 0.001). These findings have substantial implications for public policy surrounding assessments of antibody responses and possible immunity, as not all cases of COVID-19 can be assumed to generate a protective antibody response, and mild disease in particular is capable of generating very low-level anti-RBD IgG levels. These findings also have important implications for the selection of donors for convalescent plasma to be used therapeutically. [Display omitted] •We developed a sensitive, high-throughput assay for quantification of SARS-CoV-2 IgG•The assay uses liquid bead array technology for efficient and reproducible results•COVID-19 symptom severity was strongly correlated with SARS-CoV-2 SRBD IgG levels Biological Sciences; Microbiology; Virology; Viral Microbiology
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally
Lead contact
ISSN:2589-0042
2589-0042
DOI:10.1016/j.isci.2021.102052